Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1,3,8-trihydroxy-2-(3-methoxyphenyl)-6-methylanthracene-9,10-dione | - |
Homo sapiens | |
1,3,8-trihydroxy-2-(4-methoxyphenyl)-6-methylanthracene-9,10-dione | - |
Homo sapiens | |
1,3,8-trihydroxy-2-iodo-6-methylanthracene-9,10-dione | - |
Homo sapiens | |
1,3,8-trihydroxy-6-methyl-2-(1-methyl-1H-pyrazol-4-yl)anthracene-9,10-dione | - |
Homo sapiens | |
1,3,8-trihydroxy-6-methyl-2-(3-methylphenyl)anthracene-9,10-dione | - |
Homo sapiens | |
1,3,8-trihydroxy-6-methyl-2-(pyridin-3-yl)anthracene-9,10-dione | - |
Homo sapiens | |
1,3,8-trihydroxy-6-methyl-2-phenylanthracene-9,10-dione | - |
Homo sapiens | |
1,3,8-trihydroxy-6-methyl-2-[(morpholin-4-yl)methyl]anthracene-9,10-dione | - |
Homo sapiens | |
1,3,8-trihydroxy-6-methyl-2-[(piperidin-1-yl)methyl]anthracene-9,10-dione | - |
Homo sapiens | |
1,3,8-trihydroxy-6-methyl-2-[[methyl(phenyl)amino]methyl]anthracene-9,10-dione | - |
Homo sapiens | |
1,3-dibromo-2,4,5-trihydroxy-7-methylanthracene-9,10-dione | - |
Homo sapiens | |
1-chloro-2,4,5-trihydroxy-7-methylanthracene-9,10-dione | - |
Homo sapiens | |
2,4,5-trihydroxy-7-methyl-1,3-di(pyridin-3-yl)anthracene-9,10-dione | - |
Homo sapiens | |
2-chloro-1,3,8-trihydroxy-6-methylanthracen-9(10H)-one | - |
Homo sapiens | |
2-chloro-1,3,8-trihydroxy-6-methylanthracene-9,10-dione | - |
Homo sapiens | |
3-(1,3-benzoxazol-5-yl)-5,7-dihydroxy-9-methyl-3,4-dihydro-2H-anthra[2,3-e][1,3]oxazine-6,11-dione | - |
Homo sapiens | |
4-chloro-1,3,8-trihydroxy-6-methylanthracen-9(10H)-one | - |
Homo sapiens | |
5,7-dihydroxy-9-methyl-3-phenyl-3,4-dihydro-2H-anthra[2,3-e][1,3]oxazine-6,11-dione | - |
Homo sapiens | |
BMS-303141 | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P53396 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
A-549 cell | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
ACL | - |
Homo sapiens |
ATP citrate lyase | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000283 | - |
pH 8.0, 30°C | Homo sapiens | 2-chloro-1,3,8-trihydroxy-6-methylanthracen-9(10H)-one | |
0.000442 | - |
pH 8.0, 30°C | Homo sapiens | BMS-303141 | |
0.0029 | - |
pH 8.0, 30°C | Homo sapiens | 1,3-dibromo-2,4,5-trihydroxy-7-methylanthracene-9,10-dione | |
0.0038 | - |
pH 8.0, 30°C | Homo sapiens | 4-chloro-1,3,8-trihydroxy-6-methylanthracen-9(10H)-one | |
0.0075 | - |
pH 8.0, 30°C | Homo sapiens | 1,3,8-trihydroxy-2-iodo-6-methylanthracene-9,10-dione | |
0.0096 | - |
pH 8.0, 30°C | Homo sapiens | 1-chloro-2,4,5-trihydroxy-7-methylanthracene-9,10-dione | |
0.0126 | - |
pH 8.0, 30°C | Homo sapiens | 2-chloro-1,3,8-trihydroxy-6-methylanthracene-9,10-dione | |
0.0133 | - |
pH 8.0, 30°C | Homo sapiens | 1,3,8-trihydroxy-6-methyl-2-(1-methyl-1H-pyrazol-4-yl)anthracene-9,10-dione | |
0.0188 | - |
pH 8.0, 30°C | Homo sapiens | 1,3,8-trihydroxy-2-(4-methoxyphenyl)-6-methylanthracene-9,10-dione | |
0.0211 | - |
pH 8.0, 30°C | Homo sapiens | 1,3,8-trihydroxy-6-methyl-2-(pyridin-3-yl)anthracene-9,10-dione | |
0.0212 | - |
pH 8.0, 30°C | Homo sapiens | 1,3,8-trihydroxy-2-(3-methoxyphenyl)-6-methylanthracene-9,10-dione | |
0.0235 | - |
pH 8.0, 30°C | Homo sapiens | 2,4,5-trihydroxy-7-methyl-1,3-di(pyridin-3-yl)anthracene-9,10-dione | |
0.03 | - |
pH 8.0, 30°C | Homo sapiens | 1,3,8-trihydroxy-6-methyl-2-(3-methylphenyl)anthracene-9,10-dione |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | the enzyme is overexpressed in cancer cells | up |
General Information | Comment | Organism |
---|---|---|
malfunction | siRNA knockdown of ATP citrate lyase limits cancer cell proliferation and reduces cancer stemness | Homo sapiens |
metabolism | the enzyme plays a critical role in generating cytosolic acetyl CoA, a key building block for de novo fatty acid and cholesterol biosynthesis | Homo sapiens |